Log in  First Connection?

BreastArchives

Multi-modality radiomics diagnosis of breast cancer based on MRI, ultrasound and mammography
Breast
 5 min.

 Published on 08/07/2025 |  Original article (Full-text)  | Wu Jiao et al. | BMC Medical Imaging 2025; 25(1): 265

According to the 2020 Global Cancer Epidemiology Statistics (GLOBOCAN) report, breast cancer has surpassed lung cancer to become the most prevalent form of cancer, with an estimated 2.3 million new cases recorded in 2020, accounting for a staggering 11.7% of all new cancer diagnoses worldwide. It...

NRG-BR008/HERO study: a Phase III randomized trial of radiotherapy optimization for low-risk HER2-positive breast cancer
Breast
 1 min.

 Published on 01/07/2025 |  Original article (Full-text)  | Lior Z. Braunstein et al. | Future Oncology 2025; 21(16): 2017-2025

HER2-positive breast cancer historically had the highest rates of recurrence but has substantially improved outcomes with the advent of targeted anti-HER2 therapies. NRG-BR008/HERO is a Phase III randomized trial evaluating whether adjuvant radiotherapy remains beneficial in low-risk HER2-positive breast...

Use of anthracyclines and trastuzumab for breast cancer in women with and without a history of cardiovascular disease in Sweden: a national cross-sectional study
Breast
 6 min.

 Published on 24/06/2025 |  Original article (Full-text)  | Carreira Helena et al. | Cardio-Oncology 2025; 11(1): 56

Breast cancer is the most common cancer diagnosed in women worldwide, with 2.2 million newly diagnosed cases in 2022 alone [1]. Prognosis from breast cancer improved remarkably in high-income settings over recent decades. In Sweden, 5-year age-standardised relative survival from breast cancer increased...

Assessing double product derived from stress echocardiography as a prognostic indicator of major adverse cardiac events in patients with breast cancer treated with radiotherapy
Breast
 6 min.

 Published on 17/06/2025 |  Original article (Full-text)  | Garzon-Dangond Juan Manuel et al. | Cardio-Oncology 2025; 11(1): 54

In 2020, breast cancer in women surpassed lung cancer as the leading contributor to the global incidence of cancer; an estimated 2.3 million new cases were reported, representing 11.7% of all cancer cases [1]. During the past 2 decades, the survival of patients with breast cancer has notably improved....